New Delhi, March 30 – India's pharmaceutical sector is poised to take a major step towards becoming a globally competitive powerhouse driven by innovation, according to the government, as India Pharma 2026 aims to accelerate the industry's transition from volume-based growth to value and research-led expansion.
The Department of Pharmaceuticals, under the Ministry of Chemicals and Fertilizers, in collaboration with the Federation of Indian Chambers of Commerce and Industry (FICCI) and the Indian Pharmaceutical Alliance (IPA), will organize the 9th edition of India Pharma 2026 on April 13-14 at Federation House in the national capital.
The conference will serve as a key platform for discussions on how India's pharmaceutical industry can move beyond being a volume-driven market to becoming a value- and innovation-led global leader.
It will bring together policymakers, global industry leaders, researchers, and innovators to explore new opportunities and strategies.
With the theme "Discover in India: Leapfrogging Life-Sciences Innovation," the event aims to position India as a global hub for cutting-edge research and innovation in pharmaceuticals and life sciences.
The focus will be on improving healthcare access, accelerating innovation, and strengthening global health security.
Experts at the conference will discuss emerging areas such as drug discovery, complex generics, and biosimilars.
The event will also highlight India's strong manufacturing base and its fast-growing research and development ecosystem, which are helping the country strengthen its position in the global pharmaceutical value chain.
India Pharma 2026 is a flagship initiative designed to showcase India's pharmaceutical capabilities, encourage innovation, and build stronger global supply chains through collaboration and policy discussions.
FICCI, established in 1927, is one of India's oldest and largest business organizations, representing over 2.5 lakh companies across sectors.
Meanwhile, the Department of Pharmaceuticals continues to support the pharmaceutical and medical technology sectors through policy measures, infrastructure development, and industry-academia partnerships, in line with the vision of Viksit Bharat 2047.